	Association between emotion recognition and cognitive functioning in multiple sclerosis: a multilevel correlational meta-analysis. Sci Rep Degraeve B, Henry A, Lenne B. PMID: 42215611 [PubMed - as supplied by publisher]
	Neurodegenerative and inflammatory biomarkers are detectable in saliva in multiple sclerosis. Sci Rep Castelli B, Shapoori S, McMahon JM, Das K, Bocanegra-Lopez AP, Moosavizadeh S, Counihan B, Pandit A, FitzGerald U. PMID: 42215518 [PubMed - as supplied by publisher]
	From emergency myelopoiesis to chronic myeloid reprogramming: hematopoietic dysregulation in multiple sclerosis. Rev Neurosci Gu L, Ding L, Gu Z, Shi Q, Ren Y, Zhu H. PMID: 42215013 [PubMed - as supplied by publisher]
	Cognitively stimulating activities in multiple sclerosis: Results of a randomized controlled trial. Mult Scler Relat Disord Færk AK, Sellebjerg F, Lund JL, Loft M, Chow HH, Marstrand L. PMID: 42214251 [PubMed - as supplied by publisher]
	Psychological resilience as a behavioral proxy for cognitive reserve in multiple sclerosis: A theoretical reappraisal. Mult Scler Relat Disord Broche-Pérez Y. PMID: 42214249 [PubMed - as supplied by publisher]
	Building sustainable multiple sclerosis registries in Latin America: A practical framework for real-world evidence generation and healthcare access. Mult Scler Relat Disord Rojas JI, Patrucco L, Cristiano E, Becker J, Giunta DH. PMID: 42214248 [PubMed - as supplied by publisher]
	Use of High-Efficacy Therapy in Children With Multiple Sclerosis to Prevent Long-Term Disability. Neurology Sharmin S, Roos I, Labauge PM, Filippi M, Lebrun-Frenay C, Iaffaldano P, Simone M, Perini P, Magy L, Van Der Walt A, Butzkueven H, Manchon E, Alroughani R, Patti F, Pozzilli C, Eichau S, Morra VB, Laplaud DA, Maimone D, Portaccio E, Trojano M, Amato MP, Deiva K, Vukusic S, Kalincik T, MSBase, OFSEP, and Italian Multiple Sclerosis Registry Investigators. PMID: 42214041 [PubMed - indexed for MEDLINE]
	Targeting the Microbiome-NLRP3-Ferroptosis Axis in Multiple Sclerosis: Neuropharmacological Implications for Microglial Dysfunction and Demyelination. Neuropharmacology Fawzy MN, Abdelaziz AM, Shokr MM, Fathy MK. PMID: 42208757 [PubMed - as supplied by publisher]
	Efficacy and safety of ocrelizumab in primary progressive multiple sclerosis, including older patients and those with more advanced disease (ORATORIO-HAND): a multicentre, double-blind, randomised, placebo-controlled, phase 3b study. Lancet Giovannoni G, Airas L, Bove R, Cutter GR, Czarnecki M, Drulovic J, Hobart J, Kuhle J, Montalban X, Selmaj KW, Tur C, Wolinsky JS, Baldinotti A, Bonati U, Craveiro L, Giacobino C, Manfrini M, Schneble HM, Stevenson P, Wang Q, Yang K, Oh J, ORATORIO-HAND study group. PMID: 42208561 [PubMed - indexed for MEDLINE]
	Efficacy and safety of a bodyweight-adjusted higher dose of ocrelizumab in relapsing (MUSETTE) and primary progressive (GAVOTTE) multiple sclerosis: two multicentre, randomised, double-blind, parallel-group phase 3b trials. Lancet Hauser SL, Giovannoni G, Montalban X, Oh J, Bar-Or A, Sormani MP, Weber MS, Stoll S, Nicholas JA, Nehrych T, Bonek R, Selmaj K, Maciejowski M, Zecevic D, Raposo C, Owen R, Bonati U, Madjar K, Harfst E, Wang Q, Raievska A, Manfrini M, Schneble HM, Kappos L, MUSETTE and GAVOTTE Study Groups. PMID: 42208560 [PubMed - indexed for MEDLINE]
	Uncovering the role of microRNAs in response to interferon-beta therapy among multiple sclerosis patients: A systematic review. Mult Scler Relat Disord Pourseirafi M, Mousavi SR, Niazmand A, Hosseini N, Vatandoost N, Salehi M. PMID: 42208462 [PubMed - as supplied by publisher]
	Assessing nonlinear gait characteristics in multiple sclerosis: Insights from a systematic review. Clin Biomech (Bristol) Gavira-Seoane JM, Martínez-Sánchez A, Dominguez-Muñoz FJ, Leon-Llamas JL, Villafaina S. PMID: 42208448 [PubMed - as supplied by publisher]
	Cellular and molecular mechanisms of photobiomodulation: A scoping review on therapeutic potential for multiple sclerosis. Int Immunopharmacol Xie L, Zhou S, Jia H, Qi Y, Zhang C, Wan H, Jiang M. PMID: 42208329 [PubMed - as supplied by publisher]
	Psychological resilience predicts medication adherence in multiple sclerosis. Acta Neurol Belg Teken EY, Teken T, Bakay B, Uca AU, Bakay H. PMID: 42207459 [PubMed - as supplied by publisher]
	Neuropilins in Multiple Sclerosis: Dual Roles of NRP-1 in Neuroinflammation and Neuroprotection. Neuromolecular Med Goleij P, Babamohamadi M, Heidari MM, Khazeei Tabari MA, Abolfazli S, Mohammadi S, Majma Sanaye P, Arefnezhad R, Aschner M, Khan H, Rezaei Tavirani M, Movafagh A. PMID: 42207333 [PubMed - indexed for MEDLINE]
	Differences in Income Growth Between People With Multiple Sclerosis and Controls: A Norwegian Cohort Study. Eur J Neurol Høgset A, Simonsen CS, Flemmen HØ, Brunborg C, Broch L, Berg-Hansen P, Celius EG. PMID: 42206857 [PubMed - indexed for MEDLINE]
	Exploring an integrated group psychotherapy-exercise program for multiple sclerosis: a non-randomized pilot study. Neurol Sci Abelovska A, Malinova R, Sucha L, Novotna K, Friedova L, Kubala Havrdova E, Motyl J. PMID: 42203921 [PubMed - indexed for MEDLINE]
	Somatic variation in multiple sclerosis: from blood to brain. Curr Opin Genet Dev Rubio JP. PMID: 42202728 [PubMed - as supplied by publisher]
	Effect of brain gym on cognition, manual dexterity and bimanual co-ordination in patients with multiple sclerosis. Mult Scler Relat Disord Alsaid HM, Mohammed SS, Fayez ES, Hassan A, Abo-Elabbas M. PMID: 42202496 [PubMed - as supplied by publisher]
	Vocational rehabilitation for people with multiple sclerosis: A systematic scoping review of international evidence. PLoS One Gualco C, Grange E, Rotondi F, Salivetto M, Pignattelli E, Manacorda T, Grasso MG, Presicce G, Inglese M, Nasone L, Durando P, Dini G, Persechino B, Brichetto G, Ponzio M. PMID: 42201938 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 44110

Page 1 of 2206



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy